Skip to content
OpenCapital
Get started

Century Therapeutics IPSC Q3 2025 earnings

Reported November 13, 2025 · Before market open

Diluted EPS-$0.32Beat by $0.07
Revenue estimate-$83.3K
EPS estimate-$0.39

Next report

Aug 13, 2026 (in a month)
Revenue estimate$2.2M
EPS estimate-$0.11

Versus estimates

Revenue

Q1 2025$109.2MBeat by $67.9MQ4 2024$4.2MMiss by $45.4M

Diluted EPS

Q1 2026-$0.11Beat by $0.04Q4 2025-$0.25Beat by $0.03
Q3 2025-$0.32Beat by $0.07
Q2 2025-$0.38In lineQ1 2025$0.89Beat by $1.20Q4 2024-$0.43Beat by $0.02

Ask the moment Century Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Century Therapeutics report Q3 2025 earnings?
Century Therapeutics (IPSC) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Century Therapeutics's Q3 2025 revenue and EPS?
Century Therapeutics reported diluted EPS of $-0.32 for Q3 2025.
Did Century Therapeutics beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.39 by $0.07.
How did Century Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 13.5% from $-0.37.
Where can I find Century Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-110862) and the 10-Q periodic report (0001104659-25-110851) directly on SEC EDGAR. The filing index links above go to sec.gov.